Open study of quadrivalent VN-100 in healthy children

Trial Profile

Open study of quadrivalent VN-100 in healthy children

Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Influenza A virus vaccine-H5N1 (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors Daiichi Sankyo Company; Japan Vaccine; Kitasato Daiichi Sankyo Vaccine; Terumo
  • Most Recent Events

    • 08 Jun 2016 New trial record
    • 31 Mar 2016 Status changed from not yet recruiting to active, no longer recruiting.
    • 01 Oct 2015 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top